Pulmonary tuberculosis
Tuberculosis, commonly known as "pulmonary tuberculosis", is a highly contagious chronic wasting disease caused by the invasion of Mycobacterium tuberculosis into the human body. It is not affected by age, gender, race, occupation, or region. Many organs and systems of the human body can be infected with tuberculosis, among which pulmonary tuberculosis is the most common. More than 90% of pulmonary tuberculosis is transmitted through the respiratory tract. Tuberculosis patients cough, sneeze, and shout loudly, causing droplets containing tuberculosis bacteria to be sprayed out of the body, and healthy people are infected after inhaling them. Its typical manifestations are: coughing, sputum, hemoptysis, chest pain, and difficulty breathing. It is a chronic infectious disease that has a long history of endangering human health. It once spread all over the world and caused millions of deaths. my country is now one of the 22 countries with a high burden of tuberculosis in the world, and the number of tuberculosis patients ranks second in the world, second only to India. At present, there are an estimated 2 million infectious pulmonary tuberculosis patients in my country.
-
Site of disease:
lung -
Infectious :
Contagious -
Frequent population:
All people, mainly middle-aged and elderly people -
Related symptoms:
Low fever loss of appetite fatigue cough facial flushing -
Concurrent disease:
Related Drugs
Ambroxol Hydrochloride Oral Solution
Indication: This product is a mucolytic agent and can be used for expectorant treatment of acute and chronic bronchial or pulmonary diseases accompanied by sticky sputum.
Manufacturer:
Suicheng Pharmaceutical Co., Ltd.
Rifampicin Tablets
Indication: 1. This product is used in combination with other anti-tuberculosis drugs for the initial and retreatment of various tuberculosis diseases, including the treatment of tuberculous meningitis. 2. This product is used in combination with other drugs for the treatment of leprosy and non-tuberculous mycobacterial infections. 3. This product can be used in combination with vancomycin (intravenous) for severe infections caused by methicillin-resistant Staphylococcus aureus. The combination of rifampicin and erythromycin can be used for severe Legionella infections. 4. It is used for asymptomatic carriers of Neisseria meningitidis to eliminate Neisseria meningitidis in the nasopharynx; but it is not suitable for the treatment of Neisseria meningitidis infections.
Manufacturer:
Heilongjia PROVINCE Dina Pharmacy Co., Ltd.
Isoniazid Tablets
Indication: (1) Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. (2) Isoniazid alone is suitable for the prevention of various types of tuberculosis: ① Family members or close contacts of patients recently diagnosed with tuberculosis; ② Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; ③ Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose PPD test is positive; ④ Patients under 35 years old with a positive PPD test; ⑤ People who are known or suspected to be infected with HIV, whose PPD test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Isoniazid Tablets
Indication: (1) Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. (2) Isoniazid alone is suitable for the prevention of various types of tuberculosis: ① Family members or close contacts of patients recently diagnosed with tuberculosis; ② Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; ③ Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose PPD test is positive; ④ Patients under 35 years old with a positive PPD test; ⑤ People who are known or suspected to be infected with HIV, whose PPD test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Manufacturer:
Tianjin Lisheng Pharmaceutical Co., Ltd.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Manufacturer:
Xuancheng Jinfurong Pharmaceutical Co., Ltd.
Isoniazid Tablets
Indication: 1. Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. 2. Isoniazid alone is suitable for the prevention of various types of tuberculosis: 1. Family members or close contacts of patients recently diagnosed with tuberculosis; 2. Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; 3. Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose tuberculin purified protein derivative test is positive; 4. Patients under 35 years old with a positive tuberculin purified protein derivative test; 5. People who are known or suspected to be infected with HIV, whose tuberculin purified protein derivative test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Isoniazid Tablets
Indication: (1) Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. (2) Isoniazid alone is suitable for the prevention of various types of tuberculosis: ① Family members or close contacts of patients recently diagnosed with tuberculosis; ② Those who have a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and have not received formal anti-tuberculosis treatment in the past; ③ Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, and whose tuberculin purified protein derivative test is positive; ④ Those under 35 years old who have a positive tuberculin purified protein derivative test (PPD)
Manufacturer:
CSPC OUYI Pharmaceutical Co., Ltd.
Isoniazid Tablets
Indication: (1) Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. (2) Isoniazid alone is suitable for the prevention of various types of tuberculosis: ① Family members or close contacts of patients recently diagnosed with tuberculosis; ② Those who have a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and have not received formal anti-tuberculosis treatment in the past; ③ Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, and whose tuberculin purified protein derivative test is positive; ④ Those under 35 years old who have a positive tuberculin purified protein derivative test (PPD)
Manufacturer:
Shanxi Xinxing Pharmaceutical Co., Ltd.
Isoniazid Tablets
Indication: (1) Isoniazid combined with other anti-tuberculosis drugs is suitable for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. (2) Isoniazid alone is suitable for the prevention of various types of tuberculosis: ① Family members or close contacts of patients recently diagnosed with tuberculosis; ② Patients with a strong positive tuberculin purified protein derivative test (PPD) and a chest X-ray examination consistent with non-progressive tuberculosis, negative sputum bacteria, and no formal anti-tuberculosis treatment in the past; ③ Patients who are receiving immunosuppressants or long-term hormone therapy, certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, whose PPD test is positive; ④ Patients under 35 years old with a positive PPD test; ⑤ People who are known or suspected to be infected with HIV, whose PPD test is positive, or who have close contact with patients with active pulmonary tuberculosis.
Manufacturer:
JiangSu Ruinian Qianjin Pharmaceutical Co., Ltd.
Isoniazid Tablets
Indication: a) Isoniazid is used in combination with other anti-tuberculosis drugs for the treatment of various types of tuberculosis, including tuberculous meningitis and other mycobacterial infections. b) Isoniazid alone is suitable for the prevention of various types of tuberculosis: ① Family members or close contacts of patients recently diagnosed with tuberculosis ② Those with a strongly positive tuberculin purified protein derivative test (PPD) and a chest X-ray that is consistent with non-tuberculosis, negative sputum bacteria, and who have not received regular anti-tuberculosis treatment in the past ③ Patients who are receiving immunosuppressants or long-term hormone therapy, patients with certain blood diseases or reticuloendothelial system diseases (such as leukemia, Hodgkin's disease), diabetes, uremia, silicosis or gastrectomy, and whose PPD test is positive; ④ Those under 35 years old who have a positive PPD test ⑤ Those known or suspected to be infected with HIV, whose PPD test is positive, or those who have close contact with patients with active pulmonary tuberculosis.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Related Ingredients